Gilead Sciences (GILD) Acquires MiroBio
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St indexes climb after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Gilead Sciences to Acquire MiroBio
August 4, 2022 8:00 AM EDTAcquisition Provides Gilead with MiroBios Pipeline of Immune Checkpoint Agonists and Proprietary Discovery Platform
MiroBios Scientific Approach to Restoring Immune Balance for the Treatment of Autoimmune Diseases Complements Gileads Inflammation Research and Development Strategy
FOSTER CITY, Calif. & OXFORD, England--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) and MiroBio, a privately-held U.K.-based biotechnology company focused on restoring immune balance with agonists targeting immune inhibitory receptors, today announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire... More
